Did you know that Pharmaceutical companies spend 2 – 3 times as much on marketing their drugs than they do on research and development?
What this means is they invent awareness of conditions that can be treated by their drugs.
The ballooning demand for anti-depressants is a phenomenon.
In barely a decade depression has gone from a rare disorder to being classed as the second major affliction of humankind. Can a thousand-fold increase be explained other than as deliberate marketing ploy to medicalise unhappiness? A new disease of social phobia has been invented, packaged and sold along with its anti-depressant cure. The repeated claim that drugs correct a faulty ‘chemical balance’ in the brain is a theory that has no scientific base. But millions of prescriptions are issued without any test of brain chemical activity. In the USA ten million children are dosed up with antidepressants. That includes 2 million prescriptions for Seroxat.
Pharmas have cynically created dependence on happy pills. Their fable is that life should by perpetual euphoria from cradle to grave. We have been conditioned to believe that if we feel sadder today than we felt yesterday, we are sick. Stress and depression are swelling epidemics in prosperous Western countries. The impoverished developing world has other things on their minds. But unhappiness, boredom anxiety even grief and despair are the inevitable trials of the human condition. They are to be endured not to be smothered with a drug. Grief suppressed is grief multiplied. Without misery, we would not recognize happiness. Most works of art are the products of anguish. If Beethoven and Michelangelo had been on SSRIs their creative animus would have withered.
This is the Pharmas’ greatest success in disease mongering and medicalising society. Their aim, expressed to Paul Flynn MP in a letter from GlaxoSmithKline (GSK) is that half of the population of the UK should be on anti-depressants at some time in their lives.
A drugged nation delivers bounteous Pharmas profits.